Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 18/20 | 0.40 |
| ▸ | HNF4A | P41235 | 5/20 | 0.39 |
| ▸ | BRD4 | O60885 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 2/20 | 0.35 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.35 |
| ▸ | RXRB | P28702 | 3/20 | 0.34 |
| ▸ | RXRG | P48443 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6561458 | 0.89 | RXRA (0.40) | RXRAHNF4APPARGNR1H3 | |
| SCHEMBL6560970 | 0.87 | RXRA (0.40) | RXRAHNF4APPARGNR1H3RXRB | |
| SCHEMBL6560072 | 0.85 | RXRA (0.50) | RXRAHNF4APPARGNR1H3RXRB | |
| SCHEMBL6563043 | 0.83 | RXRA (0.41) | RXRAHNF4ABRD4PPARGNR1H3 | |
| SCHEMBL6559937 | 0.80 | RXRA (0.45) | RXRAPPARGNR1H3RXRBRXRG | |
| SCHEMBL6032646 | 0.80 | RARA (0.43) | RXRAHNF4ABRD4PPARGNR1H3 | |
| SCHEMBL6560253 | 0.79 | RXRA (0.37) | RXRAHNF4ARXRBRXRG | |
| SCHEMBL6559631 | 0.79 | RXRA (0.51) | RXRAHNF4APPARGNR1H3RXRB | |
| SCHEMBL6559816 | 0.78 | RXRA (0.42) | RXRAHNF4ARXRBRXRG | |
| SCHEMBL6032681 | 0.75 | L3MBTL1 (0.43) | RXRAHNF4ABRD4PPARGNR1H3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1086080-B1 | DIARYLSELENIDE COMPOUNDS AND THEIR USE IN HUMAN OR VETERINARY MEDICINE AND IN COSMETICS | GALDERMA RES & DEV (FR) | 2004-08-25 | — | — | EP | claimed |